Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-086393
Filing Date
2026-08-07
Accepted
2026-08-07 07:03:22
Documents
3
Period of Report
2026-08-07

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0300940-6k_purple.htm 6-K 14462
2 PURPLE BIOTECH REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS ea030094001ex99-1.htm EX-99.1 139054
3 PURPLE BIOTECH LTD. CONDENSED CONSOLIDATED UNAUDITED INTERIM FINANCIAL STATEMENT ea030094001ex99-2.htm EX-99.2 198218
  Complete submission text file 0001213900-26-086393.txt   353004
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 261251378
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)